| (a) | All vaccines for children and adults, including Expanded Programme on Immunisation (EPI) vaccines and COVID-19 vaccines. |
| (b) | Emergency tray medicines and supplies for the management of adverse events following immunisation (AEFI) and anaphylaxis, in compliance with the required minimum standards, including the following: |
| (i) | Adrenalin (epinephrine) 1 mg/ml (1:1000) 1 ml ampoule |
| (ii) | Hydrocortisone (100 mg/ml 200mg/2ml vial) |
| (iv) | Salbutamol 0.5% 20 ml nebulising solution OR 2.5 mg/2.5 ml OR 5 mg/2.5 ml unit dose vial for nebulisation OR salbutamol 100 mcg metered dose inhaler |
| (v) | Ipratropium 0.25 mg/2 ml OR 0.5 mg/2 ml unit dose vial for nebulisation |
| (vi) | Promethazine 25 mg/2 ml 2 ml ampoule |
| (vii) | Sodium chloride 0.9% 1 L solution |
| (viii) | 2 sets of disposable syringes with 0.01 ml graduations and 26 G IM needles |
| (ix) | 2 sets of disposable syringes (5 ml) and 24/ 26 G IM needles |
| (xi) | AEFI case reporting form |
| (xii) | Drug dosage tables for adrenaline and for hydrocortisone |
Note: Consult with the National Department of Health Standard Treatment Guidelines and Essential Medicines List for the latest updates
